![Headshot of Caroline Averius.](https://www.thetransmitter.org/wp-content/uploads/2022/10/Caroline-Averius-headshot-170.png)
Caroline Averius
Senior global patient partnership director
Roche
From this contributor
Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.
![An illustration of a scientist sitting at a desk with abstract shapes representing ideas floating above her.](https://www.thetransmitter.org/wp-content/uploads/2022/10/glennharvey_2022_10_03_spectrumnews_FINAL2_844.jpg)
Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.